Banco Santander S.A. lowered its position in CME Group Inc. (NASDAQ:CME – Free Report) by 18.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 100,971 shares of the financial services provider’s stock after selling 22,114 shares during the quarter. Banco Santander S.A.’s holdings in CME Group were worth $27,830,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Solstein Capital LLC boosted its holdings in shares of CME Group by 35.0% in the second quarter. Solstein Capital LLC now owns 1,108 shares of the financial services provider’s stock valued at $305,000 after acquiring an additional 287 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of CME Group by 2.6% in the second quarter. Envestnet Asset Management Inc. now owns 584,815 shares of the financial services provider’s stock valued at $161,187,000 after acquiring an additional 14,609 shares in the last quarter. Chilton Capital Management LLC bought a new position in shares of CME Group in the second quarter valued at approximately $105,000. Resonant Capital Advisors LLC boosted its holdings in shares of CME Group by 46.7% in the second quarter. Resonant Capital Advisors LLC now owns 1,166 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 371 shares in the last quarter. Finally, Wealthfront Advisers LLC boosted its holdings in shares of CME Group by 17.2% in the second quarter. Wealthfront Advisers LLC now owns 60,819 shares of the financial services provider’s stock valued at $16,763,000 after acquiring an additional 8,924 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
CME Group Stock Up 0.2%
Shares of NASDAQ:CME opened at $269.54 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $97.14 billion, a PE ratio of 26.12, a price-to-earnings-growth ratio of 6.65 and a beta of 0.41. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The firm has a 50 day simple moving average of $266.47 and a 200 day simple moving average of $271.90.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is 48.45%.
Insider Activity
In related news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 in the last quarter. Insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
CME has been the subject of several recent analyst reports. Morgan Stanley increased their price objective on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday. Oppenheimer raised their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Raymond James Financial reduced their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a report on Monday, October 13th. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Friday. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $284.53.
Read Our Latest Analysis on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Investing in the High PE Growth Stocks
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What is a Special Dividend?
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- What is diluted earnings per share (Diluted EPS)?
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
